Allo-hMSCs
- Generic Name
- Allo-hMSCs
Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression
- First Posted Date
- 2016-02-05
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Joshua M Hare
- Target Recruit Count
- 1
- Registration Number
- NCT02675556
- Locations
- 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
Phase 1
Terminated
- Conditions
- Hypoplastic Left Heart Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Longeveron Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT02398604
- Locations
- 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Johns Hopkins Hospital, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath